Robert Blum, President & CEO, Director at Cytokinetics, holds 401.62K shares in Cytokinetics (Ticker: CYTK), holds 96.50K shares in Gamida Cell (Ticker: GMDAQ).
What is the percentage of profitable transactions made by Robert Blum?
The percentage of profitable transactions made by Robert Blum is 45%.
What is the average return per transaction made by Robert Blum?
The average return per transaction made by Robert Blum is -26.10%.
What stocks does Robert Blum hold?
Robert Blum holds: CYTK, GMDAQ stocks.
What was Robert Blum’s latest transaction?
Robert Blum latest transaction was an Uninformative Buy of $33.35K.
What was Robert Blum's most profitable transaction?
Robert Blum’s most profitable transaction was an Informative Sell of CYTK stock on July 31, 2024. The return on the trade was 12.10%.
What is Robert Blum's role in Cytokinetics?
Robert Blum's role in Cytokinetics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.